Skip to main content
Download PDF

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus

BMC Musculoskeletal Disorders volume 23, Article number: 737 (2022) Cite this article

The Original Article was published on 14 July 2022

Correction: BMC Musculoskelet Disord 23, 672 (2022)

https://doi.org/10.1186/s12891-022-05636-8

Following the publication of the original article [1] the first author Huifan Dai needs to be changed to Huifang Dai. The author department of Huifang Dai is the same as that of Jing Xu.

The original article [1] has been updated.

Reference

  1. Dai H, Xu J. Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus. BMC Musculoskelet Disord. 2022;23:672. https://doi.org/10.1186/s12891-022-05636-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Lucheng District, Wenzhou, Zhejiang Province, People’s Republic of China

    Huifang Dai & Jing Xu

Authors
  1. Huifang Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing Xu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dai, H., Xu, J. Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus. BMC Musculoskelet Disord 23, 737 (2022). https://doi.org/10.1186/s12891-022-05707-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12891-022-05707-w

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us